fbpx

Category: News

A little less than two years after Endo Pharmaceuticals’ deal to purchase Somerset Therapeutics fell through, the Irish drugmaker is returning to the well with a much bigger acquisition.

Endo has agreed to buy BioSpecifics …

Read More

San Diego, CA, August 12, 2020 – ChemDiv Inc., a fully integrated California-based CRO, announced today the creation of a unique platform for development of drugs against coronavirus infection that would simplify and accelerate antiviral candidate selection. The …

Read More

STORE.CHEMDIV.COM — New E-Commerce resource combines specialized expertise and innovative software tools for compound sourcing with an extensive database of ChemDiv’s Discovery Chemistry Collection of over 1,600,000 screening compounds and over 60,000 Building Blocks. The …

Read More

San Diego, CA –(PR NEWS
WIRE) –April 8, 2020 — Viriom, Inc. 
today announced the initiation of a Phase 2 clinical study to evaluate the
efficacy of elsulfavirine in adults with moderate manifestations of  COVID-19 (novel coronavirus). This randomized,
open-label, multicenter study will …

Read More

SAN DIEGO, Dec. 3, 2019
/PRNewswire/ — Viriom Inc (Viriom) announces launching Segment I and Segment
II reproductive toxicity studies of Elpida® (elsulfavirine) HIV-1 therapy,
supported by preclinical services of the Division of AIDS at the National
Institute of Allergy and Infectious …

Read More

Congratulations to Nikolay Savchuk and Matthew Parker, with the release of the article “A Selective Ligand for Estrogen Receptor Proteins Discriminates Rapid and Genomic Signaling”, in which they co-authored in the Cell Chemical Biology Journal. …

Read More

ChemRar, a Russian pharmaceutical research company, has announced the successful completion of the second phase of clinical trials of a new domestic drug effective against type A and B flu strains, including those resistant to other drugs….

Read More

i2020 Accelerator announced today its plans to invest in a cutting-edge research program based out of the University of Turku (UTU), Finland. The program studies previously unrecognized protein-protein interactions that disrupt The N-methyl-D-aspartate receptor (NMDA) signaling pathways, the hyperactivity …

Read More

San
Diego (CA) – Insilico Medicine and ChemDiv, Inc. launched a new strategic
collaboration to provide certain pharmaceutical and biotechnology companies
with end-to-end drug discovery solutions. This collaboration combines the most
advanced artificial intelligence (AI) techniques with a
premium integrated drug discovery shared …

Read More

San Diego (CA) – Insilico
Medicine, in collaboration with ChemDiv, Inc., launched a drug discovery
initiative that aims to use the power of artificial intelligence for screening
chemistry space with newly designed compounds. The
initiative is expected to identify a massive of 
drug …

Read More

ChemDiv present’s new scientific poster ““First Principle” Concept in Designing Small Molecules for Targeting RNA Expansion Repeats”

The massive of the genome sequencing data has established a clear connection between expansions of short nucleotide repeats and several neurological and neuromuscular disorders. …

Read More

During “International Symposium EFMC-ASMC’19”  in Athens, September 1-5, 2019 Head of Chemistry Dr. Volodymyr Kysil will represent two posters:
Macrocyclic Peptidomimetics: Library Design …

Read More

X
Send a message
Request a call

    * Required fields

    By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      * Required fields

      By submitting this form you confirm that you have read and accepted our privacy policy. Your data will be used exclusively for this purpose.

      X